On January 30, UBS reaffirmed its Buy rating for Walmart and raised its 12-month price target, reflecting confidence in the retailer’s fundamentals. The firm highlighted Walmart’s resilient performance in the discount retail sector, underscored by its ability to generate steady same-store sales growth through both brick-and-mortar and digital channels. UBS analysts pointed to Walmart’s expanding private-label assortment and logistics investments as key drivers of future margin expansion and market share gains.

Walmart reported fiscal 2025 revenue of $681 billion, translating to approximately $1.87 billion in daily sales. The company delivered an operating margin of 4.3%, producing operating income of $29.3 billion. This represents a full percentage-point improvement from fiscal 2023, outpacing peers in the discount segment and validating initiatives such as higher-margin healthcare services and advertising. Every 0.1% rise in operating margin now contributes roughly $681 million to the bottom line.

John Furner, currently President and CEO of Walmart U.S., will assume the role of CEO at Walmart Inc. on February 1, succeeding Doug McMillon. Furner’s reputation as a tech advocate—having championed drone deliveries and AI pilot projects—suggests a continued push to scale digital offerings. He inherits a business with shares up 20% year-over-year and a market capitalization nearing $1 trillion. His early moves include appointing David Guggina, a veteran of the eCommerce division, as CEO of Walmart U.S., indicating a strategic emphasis on online growth and supply-chain optimization.

As part of its Health & Wellness expansion, Walmart elevated 3,000 pharmacy roles to new operations team-lead positions, raising average hourly pay to $28 with potential earnings up to $42. Pharmacy technicians now have a pathway to earn as much as $40.50 per hour based on certification and location, supported by company-sponsored credential programs. This compensation overhaul is designed to strengthen frontline leadership, free up pharmacists for clinical care, and reinforce Walmart’s ambition to transform its store footprint into a high-engagement healthcare network.